1. Home
  2. BDTX vs ORRF Comparison

BDTX vs ORRF Comparison

Compare BDTX & ORRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • ORRF
  • Stock Information
  • Founded
  • BDTX 2014
  • ORRF 1919
  • Country
  • BDTX United States
  • ORRF United States
  • Employees
  • BDTX N/A
  • ORRF N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • ORRF Major Banks
  • Sector
  • BDTX Health Care
  • ORRF Finance
  • Exchange
  • BDTX Nasdaq
  • ORRF Nasdaq
  • Market Cap
  • BDTX 132.5M
  • ORRF 608.7M
  • IPO Year
  • BDTX 2020
  • ORRF N/A
  • Fundamental
  • Price
  • BDTX $2.56
  • ORRF $33.96
  • Analyst Decision
  • BDTX Strong Buy
  • ORRF Buy
  • Analyst Count
  • BDTX 6
  • ORRF 2
  • Target Price
  • BDTX $14.83
  • ORRF $37.00
  • AVG Volume (30 Days)
  • BDTX 1.2M
  • ORRF 130.3K
  • Earning Date
  • BDTX 08-05-2025
  • ORRF 07-22-2025
  • Dividend Yield
  • BDTX N/A
  • ORRF 3.10%
  • EPS Growth
  • BDTX N/A
  • ORRF N/A
  • EPS
  • BDTX 0.09
  • ORRF 1.84
  • Revenue
  • BDTX $70,000,000.00
  • ORRF $203,869,000.00
  • Revenue This Year
  • BDTX N/A
  • ORRF $22.45
  • Revenue Next Year
  • BDTX N/A
  • ORRF $3.45
  • P/E Ratio
  • BDTX $28.49
  • ORRF $18.19
  • Revenue Growth
  • BDTX N/A
  • ORRF 56.29
  • 52 Week Low
  • BDTX $1.20
  • ORRF $25.57
  • 52 Week High
  • BDTX $6.75
  • ORRF $41.99
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 59.61
  • ORRF 73.99
  • Support Level
  • BDTX $2.43
  • ORRF $33.38
  • Resistance Level
  • BDTX $2.72
  • ORRF $34.27
  • Average True Range (ATR)
  • BDTX 0.17
  • ORRF 0.65
  • MACD
  • BDTX -0.01
  • ORRF 0.27
  • Stochastic Oscillator
  • BDTX 75.77
  • ORRF 93.53

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.

Share on Social Networks: